Shaanxi Meibang Pharmaceutical Group Co Ltd (605033) - Total Liabilities

Latest as of September 2025: CN¥757.69 Million CNY ≈ $110.87 Million USD

Based on the latest financial reports, Shaanxi Meibang Pharmaceutical Group Co Ltd (605033) has total liabilities worth CN¥757.69 Million CNY (≈ $110.87 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Shaanxi Meibang Pharmaceutical Group Co (605033) asset resilience to evaluate the company's liquid asset resilience ratio.

Shaanxi Meibang Pharmaceutical Group Co Ltd - Total Liabilities Trend (2017–2024)

This chart illustrates how Shaanxi Meibang Pharmaceutical Group Co Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see 605033 total asset value.

Shaanxi Meibang Pharmaceutical Group Co Ltd Competitors by Total Liabilities

The table below lists competitors of Shaanxi Meibang Pharmaceutical Group Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
G. Willi-Food International Ltd. NASDAQ:WILCF	USA	$75.10 Million
D-Link Corp TW:2332	Taiwan	NT$5.07 Billion
Lingsen Precision Industries Ltd TW:2369	Taiwan	NT$2.59 Billion
Chemclin Diagnostics Co. Ltd. A SHG:688468	China	CN¥344.10 Million
Liaoning He Eye Hospital Group Co. LTD. SHE:301103	China	CN¥290.48 Million
KNOT Offshore Partners LP NYSE:KNOP	USA	$1.04 Billion
CASIN Real Estate Development Group Co Ltd SHE:000838	China	CN¥2.15 Billion
EGing Photovoltaic Technology Co Ltd SHG:600537	China	CN¥4.06 Billion

Liability Composition Analysis (2017–2024)

This chart breaks down Shaanxi Meibang Pharmaceutical Group Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See 605033 equity financing ratio to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.99	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.66	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.40	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Shaanxi Meibang Pharmaceutical Group Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Shaanxi Meibang Pharmaceutical Group Co Ltd (2017–2024)

The table below shows the annual total liabilities of Shaanxi Meibang Pharmaceutical Group Co Ltd from 2017 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥737.37 Million ≈ $107.90 Million	+27.61%
2023-12-31	CN¥577.84 Million ≈ $84.56 Million	+21.87%
2022-12-31	CN¥474.14 Million ≈ $69.38 Million	-4.49%
2021-12-31	CN¥496.43 Million ≈ $72.64 Million	+47.53%
2020-12-31	CN¥336.50 Million ≈ $49.24 Million	+13.94%
2019-12-31	CN¥295.34 Million ≈ $43.22 Million	-4.55%
2018-12-31	CN¥309.40 Million ≈ $45.28 Million	-6.02%
2017-12-31	CN¥329.23 Million ≈ $48.18 Million	--

About Shaanxi Meibang Pharmaceutical Group Co Ltd

SHG:605033 China Agricultural Inputs

Market Cap

$365.61 Million

CN¥2.50 Billion CNY

Market Cap Rank

#13993 Global

#4191 in China

Share Price

CN¥18.48

Change (1 day)

-0.16%

52-Week Range

CN¥16.11 - CN¥31.54

All Time High

CN¥31.54